NASDAQ · Healthcare · Biotechnology
Odyssey Therapeutics, Inc.
ODTX
Odyssey Therapeutics, Inc. CEO Gary D. Glick · Market cap $515.7M.
$17.85
-0.05 · -0.28%
52w hi $20.3052w lo $15.35
Off 52w high 11.8%
71
NOTABLE
Current InsiderScore
Corp · 90d
7
7 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
7 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 11 | Shelley Chu | Buy | 11,111 | $18.00 | +$200K | 64 | |
| May 11 | Nan (Ln) Li | Buy | 1,111,111 | $18.00 | +$20.00M | 70 | |
| May 11 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 200,000 | $18.00 | +$3.60M | 67 | |
| May 11 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 222,222 | $18.00 | +$4.00M | 67 | |
| May 11 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 133,333 | $18.00 | +$2.40M | 71 | |
| May 08 | Dimension Capital II, L.P. | Buy | 1,111,111 | $18.00 | +$20.00M | 55 | |
| May 08 | Jeffrey M Leiden | Buy | 5,000 | $20.00 | +$100K | 48 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay